ChemChina is fielding requests from prospective investors to
require associate degree equity stake in either Syngenta (SYNN.VX) or ChemChina
to finance the bridge loans for the Chinese state-owned company's planned $43
billion takeover of Syngenta.
"There square measure several capital funds and banks
that square measure terribly inquisitive about partaking with U.S.A. during
this investment chance," ChemChina Chairman Ren Jianxin told a news
conference in city, Svizzera on Wed, in remarks translated from Chinese into
English.
He supplemental the refinancing of the transactions could
embody equity investors. Members of the long run funding association would be
designated in shut coordination with Syngenta's high executives, like Chairman
Michel Demare and
Chief govt John Ramsay, he said.
"They will either invest in ChemChina or into the group
action," Ren supplemental.
The initial funding was provided by a Chinese depository
financial institution and a world investor, Syngenta Chairman Demare aforesaid,
while not providing the names.
No comments:
Post a Comment